scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share (SCPH)
CUSIP: 810648105
Q2 2021 13F Holders as of 30 Jun 2021
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 53,364,241
- Total 13F shares
- 16,027,286
- Share change
- -1,123,467
- Total reported value
- $97,921,582
- Price per share
- $6.11
- Number of holders
- 35
- Value change
- -$7,160,512
- Number of buys
- 9
- Number of sells
- 35
Quarterly Holders Quick Answers
What is CUSIP 810648105?
CUSIP 810648105 identifies SCPH - scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 810648105:
Top shareholders of SCPH - scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
|
Company |
9%
|
4,797,148
|
$31,901,000 | — | 31 Mar 2021 | |
| 5AM Venture Management, LLC |
13F
|
Company |
7.2%
|
3,831,474
|
$25,479,000 | — | 31 Mar 2021 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
5.1%
|
2,731,170
|
$18,162,000 | — | 31 Mar 2021 | |
| Ikarian Capital, LLC |
13F
|
Company |
2.5%
|
1,308,699
|
$8,703,000 | — | 31 Mar 2021 | |
| AIGH Capital Management LLC |
13F
|
Company |
1.6%
|
855,142
|
$5,686,000 | — | 31 Mar 2021 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.2%
|
648,770
|
$4,314,000 | — | 31 Mar 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.2%
|
643,455
|
$4,279,000 | — | 31 Mar 2021 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.67%
|
355,690
|
$2,365,000 | — | 31 Mar 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.62%
|
329,169
|
$2,188,000 | — | 31 Mar 2021 | |
| Worth Venture Partners, LLC |
13F
|
Company |
0.4%
|
214,060
|
$1,423,000 | — | 31 Mar 2021 | |
| J. Goldman & Co LP |
13F
|
Company |
0.37%
|
198,426
|
$1,320,000 | — | 31 Mar 2021 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.36%
|
191,386
|
$1,273,000 | — | 31 Mar 2021 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.26%
|
140,967
|
$937,000 | — | 31 Mar 2021 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.25%
|
134,516
|
$895,000 | — | 31 Mar 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.22%
|
114,873
|
$764,000 | — | 31 Mar 2021 | |
| STATE STREET CORP |
13F
|
Company |
0.2%
|
104,119
|
$692,000 | — | 31 Mar 2021 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.19%
|
102,700
|
$683,000 | — | 31 Mar 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.18%
|
98,080
|
$652,000 | — | 31 Mar 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0.1%
|
54,272
|
$361,000 | — | 31 Mar 2021 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.09%
|
46,878
|
$311,000 | — | 31 Mar 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.09%
|
46,637
|
$310,000 | — | 31 Mar 2021 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.07%
|
38,891
|
$259,000 | — | 31 Mar 2021 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.06%
|
32,739
|
$218,000 | — | 31 Mar 2021 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.05%
|
24,437
|
$163,000 | — | 31 Mar 2021 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.04%
|
19,030
|
$127,000 | — | 31 Mar 2021 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.03%
|
14,397
|
$96,000 | — | 31 Mar 2021 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.02%
|
11,700
|
$78,000 | — | 31 Mar 2021 | |
| Invesco Ltd. |
13F
|
Company |
0.02%
|
10,726
|
$71,000 | — | 31 Mar 2021 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.02%
|
10,596
|
$70,000 | — | 31 Mar 2021 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.02%
|
8,264
|
$55,000 | — | 31 Mar 2021 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.01%
|
6,900
|
$46,000 | — | 31 Mar 2021 | |
| BARCLAYS PLC |
13F
|
Company |
0.01%
|
5,849
|
$39,000 | — | 31 Mar 2021 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.01%
|
4,495
|
$30,000 | — | 31 Mar 2021 | |
| AMERICAN INTERNATIONAL GROUP, INC. |
13F
|
Company |
0.01%
|
4,079
|
$27,000 | — | 31 Mar 2021 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
2,733
|
$18,000 | — | 31 Mar 2021 | |
| UBS Group AG |
13F
|
Company |
0%
|
2,384
|
$16,000 | — | 31 Mar 2021 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
2,196
|
$15,000 | — | 31 Mar 2021 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
841
|
$6,000 | — | 31 Mar 2021 | |
| Legal & General Group Plc |
13F
|
Company |
0%
|
827
|
$6,000 | — | 31 Mar 2021 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
827
|
$5,500 | — | 31 Mar 2021 | |
| Ameritas Investment Partners, Inc. |
13F
|
Company |
0%
|
475
|
$3,000 | — | 31 Mar 2021 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0%
|
470
|
$3,000 | — | 31 Mar 2021 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
465
|
$3,000 | — | 31 Mar 2021 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
357
|
$2,000 | — | 31 Mar 2021 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0%
|
261
|
$2,000 | — | 31 Mar 2021 |
Institutional Holders of scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share (SCPH) as of Q2 2021
As of 30 Jun 2021,
scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share (SCPH) was held by
35 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
16,027,286 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, 5AM Venture Management, LLC, RA CAPITAL MANAGEMENT, L.P., Ikarian Capital, LLC, J. Goldman & Co LP, AIGH Capital Management LLC, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, Russell Investments Group, Ltd., and Worth Venture Partners, LLC.
This page lists
35
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2021 vs Q1 2021 Across Filers
Q1 2021 holders
45
Q2 2021 holders
35
Holder diff
-10
| Investor | Q1 2021 Shares | Q2 2021 Shares | Share Diff | Share Chg % | Q1 2021 Value $ | Q2 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.